Lords Mark Unlisted Share Price

Lords Mark Unlisted Share Price Description – Lord’s Mark Industries is a growing industrial conglomerate in India, known for its diversified presence across railway traction, cement, steel, petrochemicals, and more. Currently trading as an unlisted company, its shares attract considerable interest from investors exploring opportunities in the unlisted market segment.

This article provides an in-depth analysis of Lord’s Mark’s unlisted share price, financial performance, market position, and investment outlook as of 2025.

Read Also: Apollo Green Energy Unlisted Share Price

Business Model of Lord’s Mark

Lord’s Mark Industries follows a diversified and sustainable business model centered around three primary business units: Diagnostic and MedTech, LED-Solar, and Paper products. The company aims to establish itself as a globally recognized brand by creating sustainable businesses that deliver value to all stakeholders. Key aspects of the company’s business model include:

• Diagnostics and MedTech: Offering rapid test kits, biochemicals, surgical consumables, and technology-driven health testing machines with expansions into genomic testing. They have around 34 types of rapid test kits and strong R&D partnerships. They have exclusive partnerships with IIT Bombay and BARC for advanced healthcare solutions.
• LED-Solar: Providing smart lighting and solar energy solutions, including rooftop solar projects for government buildings, with plans to deploy 500 MW of solar energy in the coming years.
• Paper and Printing Products: Manufacturing specialised printing papers like computer continuous stationery, railway tickets, and government-registered paper products. This division also includes a market leader in paper printing products.
• Pharmaceuticals & Hygiene Care: Under the LordsMed division, offering pharmaceuticals and hygiene care products and serving as a channel partner for Cipla Healthcare in the government sector.
• Diversification into sister companies such as automotive, insurance, biotech, and micro-biotech to enrich their business portfolio.
• Strong focus on sustainability and technology adoption with plans for expansion, including a solar module plant and increasing MedTech capacity.

Market Confidence via Fundraising

Lords Mark successfully raised INR 32.89 crore in a Series A funding round in February 2025 from investors including Brand Capital and Bennett, Coleman. A planned reverse merger with Kratos Energy is underway as a prelude to going public, with a BSE listing expected within 90–120 days. The company’s ambition is clear: a public offering later in 2025 that should raise another INR 500 crore.

Product Portfolio of Lord’s Mark

• Medical & Surgical Products: Disposable Syringes, Hypodermic Needles, Surgical Blades, IV Cannula, Scalp Vein Set, Three-Way Stopcock, PPE Kit, N95 Masks, Surgical Adhesive Tape.
• Diagnostic Kits: Rapid Test Kits for various medical conditions (multiple types).
• Biotech Products: Protein Powders and Tablets under brand names like Sante & Beaute.
• Paper Products: Computer Continuous Stationery, Railway Tickets, Reservation Charts, Coupons, Postal Acknowledgment Slips.
• LED-Solar Products: Smart LED Lights, Solar Rooftop Systems, Solar Street Lights.
• Pharmaceuticals & Hygiene: LordsMed branded pharmaceutical and hygiene care products.

Read Also: PharmEasy Unlisted Share Price

Key Highlights FY23 – 24

• The NCLT approved the final resolution plan under the Insolvency & Bankruptcy Code, completing the reverse merger of Kratos Energy & Infrastructure Ltd. with Lord’s Mark Industries Ltd. in September 2025.
• Under the scheme, shareholders of the transferor received 42,65,96,580 fully paid equity shares of INR10 each on 21 Nov 2025. The merged entity listed on BSE without a traditional IPO, aligning with your 1:1.25 swap ratio narrative and enabling public trading from late 2025 onwards.
• Lord’s Mark has secured US FDA registrations for 153 orthosurgical products, enhancing international credibility and opening export markets.
• Multiple press reports indicate Lord’s Mark is expanding global footprint, though specific USD 1M contract figures aren’t publicly broken down in exchange filings; FDA listing suggests actionable export traction.
• The company secured a 300 MW rooftop solar project contract under Uttar Pradesh New & Renewable Energy Development Agency (UPNEDA), part of renewable initiatives with multi-year operations & maintenance components, indicating scale in energy infrastructure.
  This aligns with growth ambitions in solar/renewables across Indian states.
• Publicly reported quarterly figures for 2025 show mixed performance with revenue emerging in recent periods (INR 9.48 Cr income for the period ending 30 Sep 2025).
  Broader market metrics show the company’s listed share price averaging ~INR670–INR703 in 2025, with a market cap ~INR67–INR70 Cr.
• Lord’s Mark acquired an 85 % stake in Renalyx Health Systems Ltd., focusing on AI and cloud-enabled smart haemodialysis machines, reinforcing its med-tech portfolio and R&D capabilities.
  Current share price trend shows strong one-year growth (~107 % increase), pointing to investor interest in the turnaround and expansion strategy.
• Detailed financials such as audited full FY24-25 annual revenue and profit figures are not yet released as comprehensive public annual results; however quarterly/half-year data suggest early-stage scaling post-merger.

Lord’s Mark Subsidiaries

1. Lords Mark Insurance Broking Services
2. Lords Mark Organics India
3. Lords 21 Network India
4. Lords Mark Biotech
5. Brahamastra Defence Techno Products

Read Also: Biggest Unlisted Companies in India

Lord’s Mark Board of Directors

• Mr. Rajesh Raghunath Pawar, Whole-time Director
• Ms. Feroza Jamsheed Panday, Woman Director
• Niket Jayesh Naik, Independent Director
• Mr. Nikhil Suryanath Pandey, Independent Director
• Mr. Sachidanand H. Upadhyay, Managing Director
• Mr. Vinay Benigopal Sarda, Executive Director
• Mr. Manav Kishore Teli, Executive Director

Lord’s Mark Share Price Details

Lords Mark Unlisted Share Price – Shareholding Pattern

The details of shareholders’ holding of equity shares:

Read Also: TATA Technologies Unlisted Share Price

Lords Mark Unlisted Share Price – Financial Performance

Read Also: Orbis Financial Unlisted Share Price

Lord’s Mark Unlisted Share Price FAQs